Li Luo

556 total citations · 1 hit paper
36 papers, 302 citations indexed

About

Li Luo is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Li Luo has authored 36 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in Li Luo's work include Medication Adherence and Compliance (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Li Luo is often cited by papers focused on Medication Adherence and Compliance (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Li Luo collaborates with scholars based in China, Netherlands and Sweden. Li Luo's co-authors include Xian‐Tao Zeng, Xinyue Hu, Xiaozhao Li, Siyu Yan, Yongbo Wang, Lan Yang, Ping Chen, Yuqing Deng, Yuanyuan Zhang and Xusheng Liu and has published in prestigious journals such as Scientific Reports, BMC Public Health and Medicine.

In The Last Decade

Li Luo

31 papers receiving 301 citations

Hit Papers

Global burden of benign prostatic hyperplasia, urinary tr... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Luo China 10 83 61 51 49 35 36 302
Mustafa Koyun Türkiye 13 116 1.4× 59 1.0× 71 1.4× 68 1.4× 23 0.7× 55 427
İsmail Bıyık Türkiye 11 49 0.6× 90 1.5× 64 1.3× 37 0.8× 11 0.3× 57 338
İbrahim Gökçe Türkiye 10 175 2.1× 32 0.5× 63 1.2× 90 1.8× 39 1.1× 49 478
Mehmet A. Osmanağaoğlu Türkiye 13 35 0.4× 25 0.4× 39 0.8× 38 0.8× 52 1.5× 46 371
Hatice Işık Türkiye 11 32 0.4× 35 0.6× 73 1.4× 40 0.8× 15 0.4× 29 420
Arundhathi Jeyabalan United States 14 50 0.6× 152 2.5× 92 1.8× 62 1.3× 8 0.2× 23 974
Denis K. Dudley Canada 11 84 1.0× 18 0.3× 85 1.7× 52 1.1× 19 0.5× 15 511
Yair Frenkel Israel 15 55 0.7× 25 0.4× 72 1.4× 30 0.6× 100 2.9× 38 602
Karthik Kovvuru United States 11 45 0.5× 29 0.5× 47 0.9× 28 0.6× 39 1.1× 34 305
Amrish Jain United States 10 45 0.5× 11 0.2× 117 2.3× 33 0.7× 97 2.8× 24 318

Countries citing papers authored by Li Luo

Since Specialization
Citations

This map shows the geographic impact of Li Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Luo more than expected).

Fields of papers citing papers by Li Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Luo. The network helps show where Li Luo may publish in the future.

Co-authorship network of co-authors of Li Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Li Luo. A scholar is included among the top collaborators of Li Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Luo. Li Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Wei, Dan Kuang, Li Luo, et al.. (2025). Health risks and sources of PM2.5-bound heavy metals in Southwest China: evidence from a 9-year monitoring program. BMC Public Health. 25(1). 3872–3872.
2.
Wu, Nan, Wenjie Liu, Jinlin Zhang, et al.. (2025). High-density mapping of upper loop macroreentry surrounding the superior vena cava: Substrate-evolved ablation strategy. Heart Rhythm. 23(3). 552–562.
4.
Luo, Li, Lyanne M. Kieneker, Roemer J. Janse, et al.. (2024). An increase in albuminuria is associated with a higher incidence of malignancies. Clinical Kidney Journal. 17(3). sfae009–sfae009. 2 indexed citations
6.
Zi, Hao, Mengyang Liu, Li Luo, et al.. (2024). Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Military Medical Research. 11(1). 64–64. 59 indexed citations breakdown →
8.
Luo, Li, Lyanne M. Kieneker, Bert van der Vegt, et al.. (2023). Urinary albumin excretion and cancer risk: the PREVEND cohort study. Nephrology Dialysis Transplantation. 38(12). 2723–2732. 8 indexed citations
9.
Luo, Li, Lyanne M. Kieneker, Roemer J. Janse, et al.. (2023). Albuminuria and the risk of cancer: the Stockholm CREAtinine Measurements (SCREAM) project. Clinical Kidney Journal. 16(12). 2437–2446. 5 indexed citations
10.
Luo, Li, Priya Vart, Lyanne M. Kieneker, et al.. (2023). Mediators of the association between albuminuria and incident cancer: the PREVEND study. Clinical Kidney Journal. 17(1). sfad295–sfad295. 1 indexed citations
11.
Jiang, Yuanyuan, Li Luo, Huan Tang, et al.. (2023). C5a enhances inflammation and chemotaxis of γδ T cells in malignant pleural effusion. International Immunopharmacology. 127. 111332–111332. 2 indexed citations
12.
Li, Binghui, Siyu Yan, Li Luo, et al.. (2023). Ten interleukins and risk of prostate cancer. Frontiers in Oncology. 13. 1108633–1108633. 10 indexed citations
13.
Wang, Yongbo, Lan Yang, Yuqing Deng, et al.. (2022). Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study. Journal of Translational Medicine. 20(1). 495–495. 45 indexed citations
14.
Huang, Qiong, Li Luo, Cheng‐Di Dong, et al.. (2020). <p>Refinement and Evaluation of a Chinese and Western Medication Adherence Scale for Patients with Chronic Kidney Disease: Item Response Theory Analyses</p>. Patient Preference and Adherence. Volume 14. 2243–2252. 4 indexed citations
15.
Luo, Li, Huifen Chen, Cheng‐Di Dong, et al.. (2019). <p>A Chinese and Western medication adherence scale in patients with Chronic Kidney Disease</p>. Patient Preference and Adherence. Volume 13. 1487–1495. 29 indexed citations
16.
Hu, Xinyue, Qiaoling Zhou, Li Luo, et al.. (2019). Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses. Frontiers in Cellular and Infection Microbiology. 9. 151–151. 17 indexed citations
17.
Luo, Li, et al.. (2018). Anaphylatoxins Enhance Recruitment of Nonclassical Monocytes via Chemokines Produced by Pleural Mesothelial Cells in Tuberculous Pleural Effusion. American Journal of Respiratory Cell and Molecular Biology. 60(4). 454–464. 16 indexed citations
18.
Luo, You, et al.. (2017). The efficacy of radiation therapy in adrenocortical carcinoma. Medicine. 96(17). e6741–e6741. 13 indexed citations
19.
Hu, Xinyue, Xiaozhao Li, Ling Qin, et al.. (2017). Respiratory Syncytial Virus Exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4+T cells Immune Responses. Scientific Reports. 7(1). 15207–15207. 22 indexed citations
20.
Luo, Li, et al.. (2016). Tuberculous lymphadenitis in a patient with Good syndrome. British Journal of Hospital Medicine. 77(8). 486–487. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026